Another study reported that endogenous NO plays a vital role in defining the stemness properties of colon cancer stem cells, and either a specific iNOS inhibitor or a genetic knock-down of iNOS significantly reduced the tumourigenic capacities of colon cancer stem cells (69). The gene discussed is NOS2; the disease is colonic neoplasm.